A Study in Healthy Men to Measure the Amount of BI 425809 in the Blood When Taken as a Tablet

NCT03783000 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BI 425809
DRUG: [C-14]-BI 425809

Sponsor

Boehringer Ingelheim